GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Cash And Cash Equivalents

EZZ Life Science Holdings (ASX:EZZ) Cash And Cash Equivalents : A$12.62 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Cash And Cash Equivalents?

EZZ Life Science Holdings's quarterly cash and cash equivalents increased from Dec. 2022 (A$9.59 Mil) to Jun. 2023 (A$13.83 Mil) but then stayed the same from Jun. 2023 (A$13.83 Mil) to Dec. 2023 (A$12.62 Mil).

EZZ Life Science Holdings's annual cash and cash equivalents increased from Jun. 2021 (A$8.85 Mil) to Jun. 2022 (A$10.47 Mil) and increased from Jun. 2022 (A$10.47 Mil) to Jun. 2023 (A$13.83 Mil).


EZZ Life Science Holdings Cash And Cash Equivalents Historical Data

The historical data trend for EZZ Life Science Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Cash And Cash Equivalents Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Cash And Cash Equivalents
8.41 8.85 10.47 13.83

EZZ Life Science Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial 8.95 10.47 9.59 13.83 12.62

EZZ Life Science Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


EZZ Life Science Holdings  (ASX:EZZ) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


EZZ Life Science Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


EZZ Life Science Holdings (ASX:EZZ) Business Description

Traded in Other Exchanges
N/A
Address
104 Derby Street, Silverwater, NSW, AUS, 2128
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines